Mfn Partners Management, L.P. 13F annual report

Mfn Partners Management, L.P. is an investment fund managing more than $2.72 trillion ran by Jonathan Reisman. There are currently 9 companies in Mr. Reisman’s portfolio. The largest investments include XPO Inc and Rxo Inc, together worth $1.67 trillion.

$2.72 trillion Assets Under Management (AUM)

As of 5th August 2024, Mfn Partners Management, L.P.’s top holding is 11,425,369 shares of XPO Inc currently worth over $1.21 trillion and making up 44.7% of the portfolio value. Relative to the number of outstanding shares of XPO Inc, Mfn Partners Management, L.P. owns less than approximately 0.1% of the company. In addition, the fund holds 17,310,856 shares of Rxo Inc worth $453 billion. The third-largest holding is Pennymac Finl Svcs Inc New worth $429 billion and the next is HCA Healthcare Inc worth $313 billion, with 973,898 shares owned.

Currently, Mfn Partners Management, L.P.'s portfolio is worth at least $2.72 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Mfn Partners Management, L.P.

The Mfn Partners Management, L.P. office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Jonathan Reisman serves as the General Counsel and Chief Compliance Officer at Mfn Partners Management, L.P..

Recent trades

In the most recent 13F filing, Mfn Partners Management, L.P. revealed that it had opened a new position in Forward Air and bought 903,777 shares worth $17.2 billion. This means they effectively own approximately 0.1% of the company. Forward Air makes up 1.4% of the fund's Industrials sector allocation and has decreased its share price by approximately 0.1% in the past year.

The investment fund also strengthened its position in Rxo Inc by buying 1,722,301 additional shares. This makes their stake in Rxo Inc total 17,310,856 shares worth $453 billion.

On the other hand, there are companies that Mfn Partners Management, L.P. is getting rid of from its portfolio. Mfn Partners Management, L.P. closed its position in Liberty Global Ltd on 12th August 2024. It sold the previously owned 5,499,107 shares for $97 billion. Jonathan Reisman also disclosed a decreased stake in XPO Inc by approximately 0.1%. This leaves the value of the investment at $1.21 trillion and 11,425,369 shares.

One of the largest hedge funds

The two most similar investment funds to Mfn Partners Management, L.P. are Perfromance Wealth Partners and Ritholtz Wealth Management. They manage $2.71 trillion and $2.72 trillion respectively.


Jonathan Reisman investment strategy

Mfn Partners Management, L.P.’s portfolio is diversified across 3 sectors. Currently, their heaviest sector is Industrials — making up 45.3% of the total portfolio value. The fund focuses on investments in the United States as 44.4% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 11% of the total holdings value. On the other hand, small-cap stocks make up 11.1% of the portfolio. The average market cap of the portfolio companies is close to $18.6 billion.

The complete list of Mfn Partners Management, L.P. trades based on 13F SEC filings

These positions were updated on August 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
XPO Inc
9.86%
11,425,369
$1,212,802,919,000 44.67%
Rxo Inc
11.05%
17,310,856
$452,678,885,000 16.67%
Pennymac Finl Svcs Inc New
No change
4,531,792
$428,707,523,000 15.79%
HCA Healthcare Inc
No change
973,898
$312,893,949,000 11.52%
Lithia Mtrs Inc
42.62%
890,000
$224,680,500,000 8.28%
Liberty Global Ltd
Closed
5,499,107
$97,004,247,000
Bausch Health Cos Inc
No change
6,000,000
$41,820,000,000 1.54%
Ivanhoe Electric Inc
No change
2,553,191
$23,948,932,000 0.88%
Forward Air Corp.
Opened
903,777
$17,207,914,000 0.63%
Cyclerion Therapeutics, Inc.
No change
169,460
$386,369,000 0.01%
No transactions found
Showing first 500 out of 10 holdings